Nessel, Christopher C.
Inserm · Centre Hospitalier Régional et Universitaire de Nancy · Défaillance Cardiovasculaire Aiguë et Chronique · Janssen Research & Development (United States) · Charité – Universitätsmedizin Berlin · Université de Lorraine
5 papers on CoChatORCID 0000-0001-6396-7022
Most cited papers
- Verified
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine
Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management
Cited by 9,430
- Verified
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
Fox, K. A. A., Piccini, J. P., Wojdyla, D., Becker, R. C., Halperin, J. L., Nessel, C. C., Paolini, J. F., Hankey, G. J., Mahaffey, K. W., Patel, M. R., et al. (2011) · European Heart Journal
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management
Cited by 608
- Verified
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
Hankey, G. J., Patel, M. R., Stevens, S. R., Becker, R. C., Breithardt, G., Carolei, A., Diener, H.-C., Donnan, G. A., Halperin, J. L., Mahaffey, K. W., et al. (2012) · The Lancet Neurology
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management
Cited by 354
- Verified
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
Zannad, F., Anker, S. D., Byra, W. M., Cleland, J. G. F., Fu, M., Gheorghiade, M., Lam, C. S. P., Mehra, M. R., Neaton, J. D., Nessel, C. C., et al. (2018) · New England Journal of Medicine
Heart Failure Treatment and ManagementAtrial Fibrillation Management and Outcomes
Cited by 345
- Verified
Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
Breithardt, G., Baumgartner, H., Berkowitz, S. D., Hellkamp, A. S., Piccini, J. P., Stevens, S. R., Lokhnygina, Y., Patel, M. R., Halperin, J. L., Singer, D. E., et al. (2014) · European Heart Journal
Atrial Fibrillation Management and OutcomesCardiac Valve Diseases and Treatments
Cited by 196
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free